Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × liposomal doxorubicin × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 16 Fallopian Tube Neoplasms 11 Breast Neoplasms 9 Triple Negative Breast Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Sarcoma 3 Sarcoma, Kaposi 2 Sarcoma, Ewing 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Multi-centric Castleman's Disease 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Acquired Immunodeficiency Syndrome 2 AIDS-related Kaposi sarcoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Vaccinia 1 Uterine Cervical Neoplasms 1 Rhabdomyosarcoma 1 Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Multiple Myeloma 1 Macular dystrophy, corneal type 1 1

Interventions

pembrolizumab 226 Carboplatin 199 Pemetrexed 167 Cisplatin 118 Paclitaxel 107 Nivolumab 88 durvalumab 75 osimertinib 71 Docetaxel 69 Specimen Handling 54 atezolizumab 49 Magnetic Resonance Spectroscopy 48 Drug Therapy 47 Gemcitabine 44 Radiotherapy 41 Bevacizumab 36 Radiosurgery 35 cemiplimab 33 Ipilimumab 33 130-nm albumin-bound paclitaxel 32 tislelizumab 31 Cetuximab 23 Taxes 20 Immunotherapy 20 Immune Checkpoint Inhibitors 20 amivantamab 18 Platinum Compounds 18 Blood Specimen Collection 17 Biopsy 17 Surgical Procedures, Operative 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡